サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193068

人工腱・靭帯市場：用途別（膝関節損傷、肩関節損傷、足関節損傷、その他）、エンドユーザー別（病院・診療所、ASC）：世界の機会分析および産業予測、2021-2031年

Artificial Tendons and Ligaments Market By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), By End users (Hospitals and Clinics, ASCs): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 240 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
人工腱・靭帯市場：用途別（膝関節損傷、肩関節損傷、足関節損傷、その他）、エンドユーザー別（病院・診療所、ASC）：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工腱・人工靭帯市場は2021年に6430万米ドル、2031年には1億6570万米ドルに達し、2022年から2031年にかけてCAGR10.1％で成長すると予測されています。

人工腱および人工靭帯は、天然の腱、および靭帯を補強または交換することを目的とした道具で、必要な固定装置も含まれます。人工腱は、腱の断裂や損傷の治療にも使用されます。損傷部位は弱く感じたり、痛みを伴うことがあります。腱は、筋肉を骨につなぐ帯状の柔らかい組織です。靭帯は、1つの骨と別の骨をつなぐ繊維状の結合組織です。筋肉が収縮すると、腱が骨を引っ張り、関節を動かす原因となります。腱に損傷が生じると、動きが著しく制限されることがあります。腱の損傷で最もよく影響を受ける関節は、肩、肘、足首、太もも、膝、および指です。米国整形外科学会によると、「ジャージー・フィンガー」は、腱に影響を与える最も一般的なスポーツ傷害の一つであるといわれています。腱の損傷は、関節の炎症性疾患である関節リウマチの場合にも起こります。関節リウマチは、腱を巻き込み、断裂させることがあります。

損傷した腱や靭帯は、人工の腱や靭帯から交換することで治療することができます。人工の腱や靭帯の交換は、関節に正常な動きを取り戻すために行われます。腱と靭帯の手術では、外科医が損傷した腱の上の皮膚に1つ以上の小さな切開（カット）を行い、損傷した腱または靭帯を交換し、腱の切れた端を一緒に縫い合わせます。その後、血管や神経の損傷など他の損傷がないことを周囲の組織で確認し、切開部を閉じて滅菌包帯やドレッシング材で覆います。手術後、外科医は腱が治癒するのを待つために関節を固定するか、スプリントすることを提案します。

人工腱・人工靭帯市場の成長を促す主な要因としては、高齢者人口の増加、捻挫や緊張、腱炎、打撲などのスポーツ関連傷害の増加、腱や手首の傷害の発生率の急増、子供や大人のその他の運動や身体活動への関心の高まりなどが挙げられます。例えば、2019年のJohn Hopkins Medicineの論文によると、3000万人が組織化されたスポーツに参加しており、捻挫や歪みによるスポーツ傷害は米国だけで年間350万人以上発生しています。

腱の損傷は主に、ボート漕ぎ、重い重量物の持ち上げ、窓拭き、木工、一部の組み立てライン作業などの職業活動、サッカー、バスケットボール、ペダルサイクル、サッカー、アイススケートやローラースケート、スケートボードなどのスポーツ活動など、ハードな肉体労働時に起こります。また、膝や足首、腱を補強する人工筋肉や人工腱は、低侵襲手術への傾向の高まり、スポーツ障害に対する政府の啓発活動、手術方法の開発などにより、ますます普及すると思われます。

さらに、事故の急増により腱や靭帯が損傷し、特に交通事故は人工腱や人工靭帯の手術件数の増加につながり、人工腱・人工靭帯市場の成長に拍車をかけています。例えば、Accident and Emergency（A&E）の統計によると、2019年のスポーツ傷害は2480万件で、2018年と比較して2%増加しています。さらに、低侵襲な処置の需要の増加は、人工腱・人工靭帯製品の採用を推進します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 人工腱・人工靭帯市場：用途別

  • 概要
    • 市場規模および予測
  • 膝関節損傷
    • 主な市場動向、成長要因、機会
    • 市場規模および予測：地域別
    • 市場シェア分析：国別
  • 肩の傷害
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 足と足首の傷害
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第5章 人工腱・人工靭帯市場：エンドユーザー別

  • 概要
    • 市場規模および予測
  • 病院とクリニック
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • ASC
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第6章 人工腱・人工靭帯市場：地域別

  • 概要
    • 市場規模および予測
  • 北米
    • 主要動向と機会
    • 北米市場規模・予測：アプリケーション別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：アプリケーション別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：アプリケーション別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：アプリケーション別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • 南アフリカ共和国
      • サウジアラビア
      • その他のLAMEA地域

第7章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主な発展

第8章 企業プロファイル

  • Arthrex, Inc.
  • fx solutions
  • Orthomed S.A.S
  • Neoligaments
  • Artelon
  • Corin Groups
  • Mathys AG
  • F H Orthopedics
  • Integra Lifesciences Corporation
  • Stryker Corporation
図表

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66.ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 67.ARTHREX, INC.: OPERATING SEGMENTS
  • TABLE 68.ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 69.ARTHREX, INC.: NET SALES
  • TABLE 70.ARTHREX, INC.: KEY STRATERGIES
  • TABLE 71.FX SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 72.FX SOLUTIONS: OPERATING SEGMENTS
  • TABLE 73.FX SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 74.FX SOLUTIONS: NET SALES
  • TABLE 75.FX SOLUTIONS: KEY STRATERGIES
  • TABLE 76.ORTHOMED S.A.S: COMPANY SNAPSHOT
  • TABLE 77.ORTHOMED S.A.S: OPERATING SEGMENTS
  • TABLE 78.ORTHOMED S.A.S: PRODUCT PORTFOLIO
  • TABLE 79.ORTHOMED S.A.S: NET SALES
  • TABLE 80.ORTHOMED S.A.S: KEY STRATERGIES
  • TABLE 81.NEOLIGAMENTS: COMPANY SNAPSHOT
  • TABLE 82.NEOLIGAMENTS: OPERATING SEGMENTS
  • TABLE 83.NEOLIGAMENTS: PRODUCT PORTFOLIO
  • TABLE 84.NEOLIGAMENTS: NET SALES
  • TABLE 85.NEOLIGAMENTS: KEY STRATERGIES
  • TABLE 86.ARTELON: COMPANY SNAPSHOT
  • TABLE 87.ARTELON: OPERATING SEGMENTS
  • TABLE 88.ARTELON: PRODUCT PORTFOLIO
  • TABLE 89.ARTELON: NET SALES
  • TABLE 90.ARTELON: KEY STRATERGIES
  • TABLE 91.CORIN GROUPS: COMPANY SNAPSHOT
  • TABLE 92.CORIN GROUPS: OPERATING SEGMENTS
  • TABLE 93.CORIN GROUPS: PRODUCT PORTFOLIO
  • TABLE 94.CORIN GROUPS: NET SALES
  • TABLE 95.CORIN GROUPS: KEY STRATERGIES
  • TABLE 96.MATHYS AG: COMPANY SNAPSHOT
  • TABLE 97.MATHYS AG: OPERATING SEGMENTS
  • TABLE 98.MATHYS AG: PRODUCT PORTFOLIO
  • TABLE 99.MATHYS AG: NET SALES
  • TABLE 100.MATHYS AG: KEY STRATERGIES
  • TABLE 101.F H ORTHOPEDICS: COMPANY SNAPSHOT
  • TABLE 102.F H ORTHOPEDICS: OPERATING SEGMENTS
  • TABLE 103.F H ORTHOPEDICS: PRODUCT PORTFOLIO
  • TABLE 104.F H ORTHOPEDICS: NET SALES
  • TABLE 105.F H ORTHOPEDICS: KEY STRATERGIES
  • TABLE 106.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 107.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 108.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 109.INTEGRA LIFESCIENCES CORPORATION: NET SALES
  • TABLE 110.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES
  • TABLE 111.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 112.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 113.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 114.STRYKER CORPORATION: NET SALES
  • TABLE 115.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ARTIFICIAL TENDONS AND LIGAMENTS MARKET SEGMENTATION
  • FIGURE 2.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
  • FIGURE 3.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ARTIFICIAL TENDONS AND LIGAMENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY APPLICATION,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KNEE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SHOULDER INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOOT AND ANKLE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 17.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY END USERS,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ASCS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 20.ARTIFICIAL TENDONS AND LIGAMENTS MARKET BY REGION,2021
  • FIGURE 21.U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 22.CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 23.MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 24.GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 25.FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 26.UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 27.ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 28.SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 29.REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 30.JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 31.CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 32.INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 33.AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 34.SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 36.BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44.COMPETITIVE DASHBOARD
  • FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 46.ARTHREX, INC..: NET SALES ($MILLION)
  • FIGURE 47.FX SOLUTIONS.: NET SALES ($MILLION)
  • FIGURE 48.ORTHOMED S.A.S.: NET SALES ($MILLION)
  • FIGURE 49.NEOLIGAMENTS.: NET SALES ($MILLION)
  • FIGURE 50.ARTELON.: NET SALES ($MILLION)
  • FIGURE 51.CORIN GROUPS.: NET SALES ($MILLION)
  • FIGURE 52.MATHYS AG.: NET SALES ($MILLION)
  • FIGURE 53.F H ORTHOPEDICS.: NET SALES ($MILLION)
  • FIGURE 54.INTEGRA LIFESCIENCES CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55.STRYKER CORPORATION.: NET SALES ($MILLION)
目次
Product Code: A10245

The artificial tendons and ligaments market was valued at $64.3 million in 2021 and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.

Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, "jersey finger" is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.

The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.

Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019, 30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U.S. alone, with sprains and strains.

Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.

Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.

In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market

For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.

However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Foot and Ankle Injuries
  • Knee Injuries
  • Shoulder Injuries
  • Others

By End users

  • Hospitals and Clinics
  • ASCs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
  • Key Market Players
    • Arthrex, Inc.
    • fx solutions
    • Orthomed S.A.S
    • Neoligaments
    • Artelon
    • Corin Groups
    • Mathys AG
    • F H Orthopedics
    • Integra Lifesciences Corporation
    • Stryker Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Knee Injuries
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Shoulder Injuries
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Foot and Ankle Injuries
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals and Clinics
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 ASCs
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Application
    • 6.2.3 North America Market size and forecast, by End users
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Key market trends, growth factors and opportunities
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.1.3 Market size and forecast, by End users
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Key market trends, growth factors and opportunities
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.2.3 Market size and forecast, by End users
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Key market trends, growth factors and opportunities
      • 6.2.4.3.2 Market size and forecast, by Application
      • 6.2.4.3.3 Market size and forecast, by End users
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Application
    • 6.3.3 Europe Market size and forecast, by End users
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Key market trends, growth factors and opportunities
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.1.3 Market size and forecast, by End users
      • 6.3.4.2 France
      • 6.3.4.2.1 Key market trends, growth factors and opportunities
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.2.3 Market size and forecast, by End users
      • 6.3.4.3 UK
      • 6.3.4.3.1 Key market trends, growth factors and opportunities
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.3.3 Market size and forecast, by End users
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Key market trends, growth factors and opportunities
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.4.3 Market size and forecast, by End users
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Key market trends, growth factors and opportunities
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.5.3 Market size and forecast, by End users
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Key market trends, growth factors and opportunities
      • 6.3.4.6.2 Market size and forecast, by Application
      • 6.3.4.6.3 Market size and forecast, by End users
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Application
    • 6.4.3 Asia-Pacific Market size and forecast, by End users
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Key market trends, growth factors and opportunities
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.1.3 Market size and forecast, by End users
      • 6.4.4.2 China
      • 6.4.4.2.1 Key market trends, growth factors and opportunities
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.2.3 Market size and forecast, by End users
      • 6.4.4.3 India
      • 6.4.4.3.1 Key market trends, growth factors and opportunities
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.3.3 Market size and forecast, by End users
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Key market trends, growth factors and opportunities
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.4.3 Market size and forecast, by End users
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Key market trends, growth factors and opportunities
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.5.3 Market size and forecast, by End users
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Key market trends, growth factors and opportunities
      • 6.4.4.6.2 Market size and forecast, by Application
      • 6.4.4.6.3 Market size and forecast, by End users
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Application
    • 6.5.3 LAMEA Market size and forecast, by End users
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Key market trends, growth factors and opportunities
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.1.3 Market size and forecast, by End users
      • 6.5.4.2 South Africa
      • 6.5.4.2.1 Key market trends, growth factors and opportunities
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.2.3 Market size and forecast, by End users
      • 6.5.4.3 Saudi Arabia
      • 6.5.4.3.1 Key market trends, growth factors and opportunities
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.3.3 Market size and forecast, by End users
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Key market trends, growth factors and opportunities
      • 6.5.4.4.2 Market size and forecast, by Application
      • 6.5.4.4.3 Market size and forecast, by End users

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Arthrex, Inc.
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 fx solutions
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Orthomed S.A.S
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Neoligaments
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Artelon
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Corin Groups
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mathys AG
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 F H Orthopedics
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Integra Lifesciences Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Stryker Corporation
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments